With the FDA and EMA releasing their annual reports detailing novel drug approvals in 2024, a new pharmaphorum podcast looks ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi ...

Cambridge, Massachusetts-based Vor Bio has confirmed that it will halt clinical and manufacturing operations, including its ...

For instance, studies have shown that approximately 25% of adults with diabetes reported rationing insulin in the previous ...

The GLISTEN trial of GSK's linerixibat has shown that the oral ileal bile acid transporter (IBAT inhibitor was signposted as ...

Moreover, Downing Street has indicated that the UK will receive "preferential treatment in any further tariffs imposed" as ...

Robert F Kennedy Jr has launched a project to trawl federal databases to try to identify why there has been an increase in ...

Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic ...

But international agreements are notoriously difficult to enforce, and pharma companies and patient advocates who were ...

Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...

As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have ...

Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named ...